Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

PRISMA flow chart. by Filip Stanicic (17808254)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Mediation results confirmed by Sobel test. by Katarzyna Markiewicz (20489903)

Subjects:

Effect of different doses (mg/Kg) of the defatted extract (DE) of the leaves of <i>S. malaccense</i> and <i>S. samarangense</i> on serum ALT and AST levels. Data represented as mea... by Fatma A. Moharram (9276104)

South African cassava mosaic virus (SACMV) genome structure and the effect of SACMV on cassava leaf symptoms. by Bulelani L. Sizani (21485746)

Subjects:

IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1. by Iratxe Zuazo-Gaztelu (21071939)

Specifications and effects of heating devices. by Xuemei Xiang (20756894)

Subjects:

IRE1 depletion decreases heterochromatin, DNA, and H3K9me3 methylation, and UHRF1. by Iratxe Zuazo-Gaztelu (21071939)

SBP3 KD decreases cytoadhesion of iRBCs to bovine brain endothelial cells (BBECs). by Atefeh Fathi (7370876)

Percent viability and cytotoxicity of NHBE cells are significantly altered by PAA exposure. by Ellie S. Burns (21246537)

Effects of CGA on renal biochemical markers. by Liping Bao (2936715)

Subjects:

The effects of CGA on renal histopathological injury. by Liping Bao (2936715)

Subjects:

Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and mean scores of the corresponding sensory modalities of the SPQ. by Vincenza Tarantino (182506)

Subjects:

The constitutively active form of insulin receptor and knockdown of FoxO block high temperature-mediated body fat loss. by Tucker Hopkins (20790529)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects: